.
SQZ financial statements
* Numbers in thousands
Year |
2020 | TTM |
|---|---|---|
Capitalization * |
346 900 | 62 693 |
EV * |
184 753 | 184 753 |
Stock price $ |
24.07 | 4.35 |
Number of shares * |
14 412 | 14 412 |
EPS |
-3,51 | -3,51 |
Revenue * |
20 998 | 20 998 |
Net income * |
-50 521 | -50 521 |
Operating profit * |
-51 058 | -51 058 |
Total liabilities * |
103 942 | 103 942 |
Net debt * |
-123 262 | -123 262 |
Total assets * |
231 141 | 231 141 |
Equity * |
127 199 | 127 199 |
Cash and investments * |
170 357 | 170 357 |
Over the past 10 years, the maximum capitalization of SQZ Biotechnologies Company is 346 900, the minimum is 346 900. Maximum net income 0, Minimum net income -50 521. The maximum price of SQZ shares is 24.07, the minimum price is 24.07.
.
SQZ valuation
Year |
2020 | TTM |
|---|---|---|
P/E |
-6,87 | -1,24 |
P/B |
2,73 | 0,49 |
P/S |
16,52 | 2,99 |
E/P |
-15% | -81% |
P/FCF |
-7,83 | -1,41 |
.
SQZ profitability
Year |
2020 | TTM |
|---|---|---|
ROE |
-40% | |
ROA |
-22% | |
ROIC |
-27% |